ClinicalTrials.gg
Drug

Riociguat clinical trials

Also written Adempas and MK-4836.

studies test it
48
open now
2
in phase 3
7
first study started
2007

How each study uses riociguat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the riociguat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
8 Oct 2013 · ADEMPAS · NDA 204819 (FDA, Drugs@FDA)
European Union
27 Mar 2014 · Adempas · EMEA/H/C/002737 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Riociguat (Adempas, BAY63-2521)
16
Riociguat
13
Riociguat (BAY63-2521)
4
Riociguat (Adempas, BAY 63-2521)
3
Riociguat (Adempas)
2

Brand

Adempas
12

Development codes

MK-4836
2
NDA 204819
1
BAY 63-2521
1

Studies by the year they started

48 studies that test it; most in 2014 (7)

Studies that test riociguat, by start year
YearStudies
20071
20083
20093
20106
20122
20131
20147
20153
20165
20173
20183
20202
20211
20223
20233
20241
20251

By phase

A phase 1/2 study counts in both.

Phase 1
12
Phase 2
18
Phase 3
7
Phase 4
9
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 30 · Other 18

Bayer (27) · Actelion (2) · Medical University of Vienna (2) · Maastricht University (2) · Heidelberg University (2) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · University of Colorado, Denver (1) · Danish Headache Center (1)

Often tested with

Tested in the same studies.

Macitentan (3) · Sildenafil (2) · Propylthiouracil (2) · Perphenazine (2) · Selexipag (1) · Sotatercept (1) · Rosuvastatin (1) · Ethinyl estradiol, levonorgestrel drug combination (1)

Studies

Open first, then newest update. How each study uses riociguat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 48

See all 48 studies that test riociguat →

Given beside what is tested · 1 — riociguat is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with riociguat

Codes

What other systems call riociguat · ClinicalTrials.gg INT005474

  • MeSH (NLM) C542595riociguatConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) RU3FE2Y4XIRIOCIGUATConfirmed FDA, NLM, Wikidata
  • RxNorm 1439816Confirmed FDA, Wikidata
  • Wikidata Q2154494riociguatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152225RiociguatOne source FDA
  • DrugBank DB08931One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.